We are entering a new era of digital biology. This week, we break down the latest breakthroughs in genomic engineering, moving beyond standard CRISPR to advanced tools like base editing.

We examine how artificial intelligence is accelerating scientific discovery and optimizing gene regulation. The episode also covers the ethical implications of rewriting DNA and the economic shift in venture capital, as institutional funding moves toward high-risk, high-reward research.